218 Results for "

cluster

" in MedChemExpress (MCE) Product Catalog:
Products (218)

218 Results for "cluster" in MCE Product Catalog:

130
130 Publications Verification
Cat. No.: HY-12040
CAS No.: 488832-69-5
Pureté:  99.80%
Synonyms: STA-4783
Domaines de recherche:  

Cancer

Elesclomol (STA-4783) is a potent copper ionophore and promotes copper-dependent cell death (cuproptosis). Elesclomol specifically binds ferredoxin 1 (FDX1) α2/α3 helices and β5 strand. Elesclomol inhibits FDX1-mediated Fe-S cluster biosynthesis. Elesclomol is an oxidative stress inducer that induces cancer cell apoptosis. Elesclomol is a reactive oxygen species (ROS) inducer. Elesclomol can be used for Menkes and associated disorders of hereditary copper deficiency research .
loading...
    loading...
57
57 Cited Publications
Cat. No.: HY-17409
CAS No.: 1400-61-9
Nystatin is an orally active polyene antifungal antibiotic effective against yeast and mycoplasma. Nystatin increases the permeability of plasma membranes to small monovalent ions, including chloridion . Nystatin is a cholesterol-sequestering agent , partially prevents Oxaliplatin-induced lipid raft aggregation, DR4 and DR5 clustering, and thereby reduces apoptosis .
loading...
    loading...
10
10 Cited Publications
Cat. No.: HY-15666
CAS No.: 1257628-77-5
Pureté:  99.65%
Synonyms: GZD824; HQP1351
Target:  

Bcr-Abl

Domaines de recherche:  

Cancer

Olverembatinib (GZD824) is a potent and orally active pan-Bcr-Abl inhibitor. Olverembatinib potently inhibits a broad spectrum of Bcr-Abl mutants. Olverembatinib strongly inhibits native Bcr-Abl and Bcr-Abl T315I with IC50s of 0.34 nM and 0.68 nM, respectively. Olverembatinib has antitumor activity . Olverembatinib is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
loading...
    loading...
10
10 Cited Publications
Cat. No.: HY-15666A
CAS No.: 1421783-64-3
Pureté:  99.81%
Synonyms: GZD824 dimesylate; HQP1351 dimesylate
Target:  

Bcr-Abl

Domaines de recherche:  

Cancer

Olverembatinib (GZD824) dimesylate is a potent and orally active pan-Bcr-Abl inhibitor. Olverembatinib dimesylate potently inhibits a broad spectrum of Bcr-Abl mutants. Olverembatinib dimesylate strongly inhibits native Bcr-Abl and Bcr-Abl T315I with IC50s of 0.34 nM and 0.68 nM, respectively. Olverembatinib dimesylate has antitumor activity . Olverembatinib (dimesylate) is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-122214
CAS No.: 775294-71-8
Pureté:  99.84%
Target:  

Autophagy

Domaines de recherche:  

Cancer

AC-73 is a first specific, orally active inhibitor of cluster of differentiation 147 (CD147), which specifically disrupts CD147 dimerization, thereby mainly suppressing the CD147/ERK1/2/STAT3/MMP-2 pathways. AC-73 inhibits the motility and invasion of hepatocellular carcinoma cells . AC-73 is also an anti-proliferative agent and an inducer of autophagy in leukemic cells .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-P702520
Pureté:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: LRP1; Apolipoprotein E Receptor; Prev. A2MR; TbetaR-V/LRP-1/IGFBP-3 Receptor; Prev. APR; Type V Tgf-Beta Receptor; APOER; Alternative Protein LRP1; Alpha-2-Macroglobulin Receptor; CD91 Antigen; IGFBP3R1; LRP1 Protein; IGFBP-3R; IGFBP3R; LRP1A; TGFBR5; CD9
Species:  
Source:  
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P99021
CAS No.: 1578199-75-3
Synonyms: LY 2951742

Target:  

CGRP Receptor

Domaines de recherche:  

Neurological Disease Inflammation/Immunology

Galcanezumab (LY 2951742) is a humanized IgG4 monoclonal antibody against the CGRP ligand. Galcanezumab can be used for migraine or cluster headaches research .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-18377
CAS No.: 1420071-30-2
Synonyms: DR5 Activator
Target:  

TNF Receptor Apoptosis

Domaines de recherche:  

Cancer

Bioymifi (DR5 Activator), a potent TRAIL receptor DR5 activator, binds to the extracellular domain (ECD) of DR5 with a Kd of 1.2 μM. Bioymifi can act as a single agent to induce DR5 clustering and aggregation, leading to apoptosis .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-B1243
CAS No.: 550-83-4
Target:  

Sodium Channel

Domaines de recherche:  

Neurological Disease

Propoxycaine hydrochloride is a voltage-gated sodium channel inhibitor. Propoxycaine hydrochloride delays monophasic A spike action potential recovery. Propoxycaine hydrochloride increases bulk lateral, rotational, and annular lipid fluidity in neuronal membrane lipid bilayers, with greater inner monolayer fluidization, and induces membrane protein clustering. Propoxycaine hydrochloride can be used for the research of pain .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P70809
Pureté:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: CD24; Signal Transducer CD24; CD24 Molecule; Small Cell Lung Carcinoma cluster 4 Antigen; CD24A; CD24 Antigen; CD24 Antigen (Small Cell Lung Carcinoma cluster 4 Antigen)
Species:  
Source:  
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P80922
Synonyms: H3K27me3; H3 histone; HIST1H3A; Histone cluster 1; H3a

Host:  

Rabbit

Application:  

WB, IHC-P, ICC/IF

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P99342
CAS No.: 2415933-40-1
Synonyms: REGN10987

Target:  

SARS-CoV

Domaines de recherche:  

Infection

Imdevimab (REGN10987) is a human monoclonal antibody that targets SARS-CoV-2 virus. Imdevimab can be used in combination with Casirivimab (HY-P99341) to reduce viral load and transiently increases anti-receptor-binding domain IgG titers. Imdevimab maintains most of its neutralization activity against viruses with B.1.1.7, B.1.351 and mink cluster 5 spike proteins .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P81098
Synonyms: CD34 antigen; CD34 molecule; cluster designation 34; Hematopoietic progenitor cell antigen CD34; HPCA1; CD34_HUMAN.

Host:  

Rabbit

Application:  

WB, IHC-P, IHC-F, ICC/IF

Reactivity:  

Human, Mouse

loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-155539
CAS No.: 2916371-59-8
Pureté:  99.17%
Domaines de recherche:  

Inflammation/Immunology

Cisd2 agonist 2 (compound 6) is a Cisd2 activator (EC50=191 nM), and Cisd2 levels are associated with non-alcoholic fatty liver disease (NAFLD). Cisd2 agonist 2 has no significant in vivo toxicity in Cisd2hKO-het mice (heterozygous hepatocyte-specific Cisd2 knockout). Cisd2 (CDGSH iron sulfur domain 2) is a zinc finger protein that is mainly localized in the endoplasmic reticulum or mitochondrial membrane. Cisd2 participates in mitochondrial function by forming homodimers containing two redox-active 2Fe-2S clusters .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P72332
Pureté:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: H3C1; Histone H3/C; Prev. HIST1H3A; HIST1H3J; Prev. H3FA; HIST1H3I; H3/A; HIST1H3H; Histone cluster 1 H3 Family Member A; HIST1H3G; H3 Histone Family, Member A; HIST1H3F; Histone cluster 1, H3a; HIST1H3E; Histone 1, H3a; HIST1H3D; Histone H3.1; HIST1H3B;
Species:  
Source:  
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P704765
Pureté:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: LRP1; Apolipoprotein E Receptor; Prev. A2MR; TbetaR-V/LRP-1/IGFBP-3 Receptor; Prev. APR; Type V Tgf-Beta Receptor; APOER; Alternative Protein LRP1; Alpha-2-Macroglobulin Receptor; CD91 Antigen; IGFBP3R1; LRP1 Protein; IGFBP-3R; IGFBP3R; LRP1A; TGFBR5; CD9
Species:  
Source:  
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P704766
Pureté:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: LRP1; Apolipoprotein E Receptor; Prev. A2MR; TbetaR-V/LRP-1/IGFBP-3 Receptor; Prev. APR; Type V Tgf-Beta Receptor; APOER; Alternative Protein LRP1; Alpha-2-Macroglobulin Receptor; CD91 Antigen; IGFBP3R1; LRP1 Protein; IGFBP-3R; IGFBP3R; LRP1A; TGFBR5; CD9
Species:  
Source:  
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P704767
Pureté:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: LRP1; Apolipoprotein E Receptor; Prev. A2MR; TbetaR-V/LRP-1/IGFBP-3 Receptor; Prev. APR; Type V Tgf-Beta Receptor; APOER; Alternative Protein LRP1; Alpha-2-Macroglobulin Receptor; CD91 Antigen; IGFBP3R1; LRP1 Protein; IGFBP-3R; IGFBP3R; LRP1A; TGFBR5; CD9
Species:  
Source:  
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P86672
Synonyms: H3 histone family member E pseudogene; H3 histone family, member A; H3/A; H31_HUMAN; H3F3; H3FA; Hist1h3a; HIST1H3B; HIST1H3C; HIST1H3D; HIST1H3E; HIST1H3F; HIST1H3G; HIST1H3H; HIST1H3I; HIST1H3J; HIST3H3; histone 1, H3a; Histone cluster 1, H3a; Histone H3 3 pseudogene; Histone H3.1; Histone H3/a; Histone H3/b; Histone H3/c; Histone H3/d; Histone H3/f; Histone H3/h; Histone H3/i; Histone H3/j; Histone H3/k; Histone H3/l; H3.1; H3/d; H3C1; H3C10; H3C11; H3C12; H3C2; H3C3; H3C4; H3C7; H3C8; H3FD;

Host:  

Rabbit

Application:  

IHC-P, IHC-F, IF-Tissue, WB, FC, ICC/IF

Reactivity:  

Human, Rat, Mouse

loading...
    loading...
Cat. No.: HY-W698249
CAS No.: 299-29-6
Target:  

Ferroptosis Bacterial

Domaines de recherche:  

Cardiovascular Disease Infection

Ferrous gluconate is a highly water-soluble iron-containing agent with high bioavailability and bactericidal activity. As a non-heme iron, Ferrous gluconate is used for meat product fortification and improvement of iron deficiency anemia. Ferrous gluconate induces ferroptosis in E. coli through Fe 2+ infiltration, reactive oxygen species burst, lipid peroxidation and direct interaction with DNA. Ferrous gluconate also downregulates the SOS responsive transcriptional repressor LexA. In addition, Ferrous gluconate regulates multiple key pathways in E. coli such as fatty acid metabolism, iron-sulfur cluster assembly and pyruvate metabolism, and is applied in studies related to *E. coli* infection and iron deficiency anemia .
loading...
    loading...